Treatment Indications: restoration of significant volume loss and deep facial depressions;, high‑support volumization in cheekbones, mid‑face, and jawline;, structural contouring and facial oval redefinition;, correction of deep folds and severe atrophy;, non‑surgical cheek and chin augmentation;, creation of pronounced facial projection and sharp contour definition
Release form: 1 × 1.0 mL pre‑filled sterile glass syringe
Indications: deep dermal to subdermal and supraperiosteal injection for major volume restoration and structural support;, utilizing SHINE (Stabilized Hyaluronic acid & Improved Novel Efficacy) technology for high viscosity, maximum cohesivity, and stable shape retention with minimal residual BDDE;, providing pronounced lifting effect, even tissue integration, and minimal migration (effect duration ~12–18 months)